Home

Neuroscientific Biopharmaceuticals Ltd

ASX Code

NSB

Sector

Pharmaceuticals- Biotechnology & Life Sciences

Investor Centre

https://neuroscientific.com/investors/#asx-announcements

Website

https://neuroscientific.com/

About

Biopharmaceutical innovation and world class R&D NSB (ASX:NSB) is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need. The NSB product portfolio includes several therapeutic peptides that are modeled on the domains of a naturally occurring protein called Metallothionein-II (MT-II). EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II.

News

NeuroScientific Biopharmaceuticals (ASX: NSB) – Webinar Presentation

Peptide based therapies for neurodegenerative conditions